Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda)E Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Amr Morsy
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 13.9yrs |
| CEO ownership | 2.2% |
| Management average tenure | no data |
| Board average tenure | 7.9yrs |
Recent management updates
Recent updates
CEO
Amr Morsy
13.9yrs
Tenure
Dr. Amr Abdallah Morsy serves as Chief Executive Officer at Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (formerly known as Rameda Pharmaceutical) and its Executive Direc...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 13.9yrs | no data | 2.23% EGP 114.2m | |
| Group CFO & Executive Director | 5.9yrs | no data | 0.24% EGP 12.3m | |
| Independent Non-Executive Director | 5.9yrs | no data | no data | |
| Non-Executive Vice Chairman | 13.9yrs | no data | 0.00053% EGP 27.2k | |
| Non-Executive Chairman of the Board | 13.9yrs | no data | 0.00053% EGP 27.2k | |
| Non-Executive Director | 8.9yrs | no data | no data | |
| Non-Executive Director | 8.9yrs | no data | no data | |
| Non-Executive Director | 6.9yrs | no data | no data | |
| Independent Non-Executive Director | 1.8yrs | no data | no data | |
| Non-Executive Director | 2.2yrs | no data | no data |
7.9yrs
Average Tenure
48yo
Average Age
Experienced Board: RMDA's board of directors are considered experienced (7.9 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 16:41 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. is covered by 12 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Eman Maree | Arab African International Securities |
| Ahmed Rashad | Beltone Financial |
| Aly Adel | Beltone Financial |